Gland Pharma (GLAND) — Announcement

📢 Key Event
Gland Pharma reports 20% YoY revenue growth to INR18,003 million in Q1 FY27, driven by U.S. and CDMO expansion.

🔄 What Changed
Revenue growth accelerated to 20% YoY, PAT margin improved to 18%, R&D spend rose 16% YoY to 4% of revenue

🔮 What's Next
INR2,000 crore capex program for CDMO expansion, USD90-100 million revenue potential from 2029 agreement

💡 Investor Takeaway
Shareholders benefit from accelerating growth in high-margin CDMO and B2B segments, supported by strong cash reserves and strategic capex.

Gland Pharma reported 20% YoY revenue growth to INR18,003 million in Q1 FY27, driven by 32% growth in the U.S. market and strong CDMO and B2B performance. Gross margins improved to 65% due to favorable product mix, while PAT rose 47% to INR3,170 million (18% margin). The company secured strategic agreements, including a USD90-100 million revenue potential from 2029, and plans INR2,000 crore capex for CDMO expansion. R&D investment increased 16% to INR772 million (4% of revenue), focusing on complex injectables and delivery platforms. Cash remains robust at INR35,466 million, supporting ongoing growth initiatives.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAND ✨ Ask AI About This

About Gland Pharma Limited (GLAND)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹47,316.21 Cr P/E: 41.9 ROE: 10.9% ROCE: 15.2% Div Yield: 0.70%

View full GLAND stock details →

📡 Get AI alerts when GLAND files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAND — Free

💡 Ask AI about this filing

"How will the USD90-100 million revenue target from the 2029 agreement be achieved?" "What is the expected timeline for CDMO contribution to reach 30% of consolidated revenue?" "How will the INR2,000 crore capex be allocated across new manufacturing sites?"

Ask AI Free →

📊 More GLAND filings

See all GLAND filings →

🔥 Also filed on 17 August 2026

PREMIERENE Premier Energies Limited Announcement ABCAPITAL Aditya Birla Capital Limited Corporate Action VIVIMEDLAB Vivimed Labs Limited Announcement GSPCROP GSP Crop Science Limited Financial Results SEDEMAC SEDEMAC Mechatronics Limited Annual Report AFFLE Affle 3i Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAND files new disclosures

Track GLAND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAND — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd